223 related articles for article (PubMed ID: 12606634)
1. Distinct recognition of OX1 and OX2 receptors by orexin peptides.
Ammoun S; Holmqvist T; Shariatmadari R; Oonk HB; Detheux M; Parmentier M; Akerman KE; Kukkonen JP
J Pharmacol Exp Ther; 2003 May; 305(2):507-14. PubMed ID: 12606634
[TBL] [Abstract][Full Text] [Related]
2. Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation.
Okumura T; Takeuchi S; Motomura W; Yamada H; Egashira Si S; Asahi S; Kanatani A; Ihara M; Kohgo Y
Biochem Biophys Res Commun; 2001 Feb; 280(4):976-81. PubMed ID: 11162621
[TBL] [Abstract][Full Text] [Related]
3. Structural properties of orexins for activation of their receptors.
Lang M; Bufe B; De Pol S; Reiser O; Meyerhof W; Beck-Sickinger AG
J Pept Sci; 2006 Apr; 12(4):258-66. PubMed ID: 16138386
[TBL] [Abstract][Full Text] [Related]
4. Agonist ligand discrimination by the two orexin receptors depends on the expression system.
Putula J; Turunen PM; Jäntti MH; Ekholm ME; Kukkonen JP
Neurosci Lett; 2011 Apr; 494(1):57-60. PubMed ID: 21362456
[TBL] [Abstract][Full Text] [Related]
5. Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction.
Putula J; Turunen PM; Johansson L; Näsman J; Ra R; Korhonen L; Kukkonen JP
FEBS Lett; 2011 May; 585(9):1368-74. PubMed ID: 21510948
[TBL] [Abstract][Full Text] [Related]
6. Regulation of OX1 orexin/hypocretin receptor-coupling to phospholipase C by Ca2+ influx.
Johansson L; Ekholm ME; Kukkonen JP
Br J Pharmacol; 2007 Jan; 150(1):97-104. PubMed ID: 17115071
[TBL] [Abstract][Full Text] [Related]
7. Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor.
Takai T; Takaya T; Nakano M; Akutsu H; Nakagawa A; Aimoto S; Nagai K; Ikegami T
J Pept Sci; 2006 Jul; 12(7):443-54. PubMed ID: 16429482
[TBL] [Abstract][Full Text] [Related]
8. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
[TBL] [Abstract][Full Text] [Related]
9. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
10. Involvement of TRPC3 channels in calcium oscillations mediated by OX(1) orexin receptors.
Peltonen HM; Magga JM; Bart G; Turunen PM; Antikainen MS; Kukkonen JP; Akerman KE
Biochem Biophys Res Commun; 2009 Jul; 385(3):408-12. PubMed ID: 19464259
[TBL] [Abstract][Full Text] [Related]
11. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors.
Smart D; Jerman JC; Brough SJ; Neville WA; Jewitt F; Porter RA
Br J Pharmacol; 2000 Apr; 129(7):1289-91. PubMed ID: 10742282
[TBL] [Abstract][Full Text] [Related]
12. Food-induced expression of orexin receptors in rat duodenal mucosa regulates the bicarbonate secretory response to orexin-A.
Bengtsson MW; Mäkelä K; Sjöblom M; Uotila S; Akerman KE; Herzig KH; Flemström G
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G501-9. PubMed ID: 17585016
[TBL] [Abstract][Full Text] [Related]
13. Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans.
Burdyga G; Lal S; Spiller D; Jiang W; Thompson D; Attwood S; Saeed S; Grundy D; Varro A; Dimaline R; Dockray GJ
Gastroenterology; 2003 Jan; 124(1):129-39. PubMed ID: 12512037
[TBL] [Abstract][Full Text] [Related]
14. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
Xu TR; Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
[TBL] [Abstract][Full Text] [Related]
15. Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B.
Asahi S; Egashira S; Matsuda M; Iwaasa H; Kanatani A; Ohkubo M; Ihara M; Morishima H
Bioorg Med Chem Lett; 2003 Jan; 13(1):111-3. PubMed ID: 12467628
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor.
Langmead CJ; Jerman JC; Brough SJ; Scott C; Porter RA; Herdon HJ
Br J Pharmacol; 2004 Jan; 141(2):340-6. PubMed ID: 14691055
[TBL] [Abstract][Full Text] [Related]
17. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum.
Kohlmeier KA; Inoue T; Leonard CS
J Neurophysiol; 2004 Jul; 92(1):221-35. PubMed ID: 14999052
[TBL] [Abstract][Full Text] [Related]
18. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
[TBL] [Abstract][Full Text] [Related]
19. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
20. Orexin B inhibits proliferation and stimulates specialized function of cultured rat calvarial osteoblast-like cells.
Ziolkowska A; Rucinski M; Tyczewska M; Malendowicz LK
Int J Mol Med; 2008 Dec; 22(6):749-55. PubMed ID: 19020772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]